• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING Back to Search Results
Model Number 24653
Device Problems Premature Activation (1484); Material Deformation (2976)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 03/12/2020
Event Type  malfunction  
Event Description
It was reported that inadvertent deployment and stent damage occurred.The severely stenosed target lesion was located in the superficial femoral artery (sfa).A 6x120, 130cm eluvia drug-eluting vascular stent system was selected for use.During the insertion of the catheter along the guidewire, the stent extended outside the patient's body and changed into an unusable condition.The lever or fixture on the stent was untouched and unfolded in the process of pushing the catheter.The procedure was completed using another of the same device.There were no patient complications.
 
Manufacturer Narrative
Device evaluated by mfr: returned product consisted of an eluvia self-expanding stent system.The outer sheath, tip, inner sheath and the remainder of the device were checked for damage.Visual examination revealed a kink to the outer sheath at the nosecone.The stent was partially deployed 13mm from the distal end of the middle sheath.Microscopic examination revealed no additional damages.Inspection of the remainder of the device, revealed no other damage or irregularities.
 
Event Description
It was reported that inadvertent deployment and stent damage occurred.The severely stenosed target lesion was located in the superficial femoral artery (sfa).A 6x120, 130cm eluvia drug-eluting vascular stent system was selected for use.During the insertion of the catheter along the guidewire, the stent extended outside the patient's body and changed into an unusable condition.The lever or fixture on the stent was untouched and unfolded in the process of pushing the catheter.The procedure was completed using another of the same device.There were no patient complications.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
MDR Report Key9910060
MDR Text Key185970395
Report Number2134265-2020-04108
Device Sequence Number1
Product Code NIU
Combination Product (y/n)N
PMA/PMN Number
P180011
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 05/20/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/01/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date07/23/2021
Device Model Number24653
Device Catalogue Number24653
Device Lot Number0024261609
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/14/2020
Date Manufacturer Received04/30/2020
Patient Sequence Number1
Patient Age70 YR
-
-